ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

1978-79 Budgets By Program Areas

June 3, 1977

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84

June 29, 1984

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

October 23, 1981

AACR Plans Office in Singapore.

November 30, 2007

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005